BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 17954784)

  • 1. Gout and risk of Parkinson disease: a prospective study.
    Alonso A; Rodríguez LA; Logroscino G; Hernán MA
    Neurology; 2007 Oct; 69(17):1696-700. PubMed ID: 17954784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gout and the risk of Parkinson's disease: a cohort study.
    De Vera M; Rahman MM; Rankin J; Kopec J; Gao X; Choi H
    Arthritis Rheum; 2008 Nov; 59(11):1549-54. PubMed ID: 18975349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical associations between gout and multiple sclerosis, Parkinson's disease and motor neuron disease: record-linkage studies.
    Pakpoor J; Seminog OO; Ramagopalan SV; Goldacre MJ
    BMC Neurol; 2015 Feb; 15():16. PubMed ID: 25884318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of Parkinson's disease in a gout Mediterranean population: A case-control study.
    Pou MA; Orfila F; Pagonabarraga J; Ferrer-Moret S; Corominas H; Diaz-Torne C
    Joint Bone Spine; 2022 Nov; 89(6):105402. PubMed ID: 35504516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between gout and the development of Parkinson's disease: a systematic review and meta-analysis.
    Fazlollahi A; Zahmatyar M; Alizadeh H; Noori M; Jafari N; Nejadghaderi SA; Sullman MJM; Gharagozli K; Kolahi AA; Safiri S
    BMC Neurol; 2022 Oct; 22(1):383. PubMed ID: 36221048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of Parkinson's disease following gout: a population-based retrospective cohort study in Taiwan.
    Hu LY; Yang AC; Lee SC; You ZH; Tsai SJ; Hu CK; Shen CC
    BMC Neurol; 2020 Sep; 20(1):338. PubMed ID: 32900384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gout and the risk of Alzheimer's disease: a population-based, BMI-matched cohort study.
    Lu N; Dubreuil M; Zhang Y; Neogi T; Rai SK; Ascherio A; Hernán MA; Choi HK
    Ann Rheum Dis; 2016 Mar; 75(3):547-51. PubMed ID: 25739830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Association between Gout and Parkinson's Disease: A Nationwide Population-Based Cohort Study in Korea.
    Kim JH; Choi IA; Kim A; Kang G
    Medicina (Kaunas); 2021 Nov; 57(12):. PubMed ID: 34946237
    [No Abstract]   [Full Text] [Related]  

  • 9. Urate and the risk of Parkinson's disease in men and women.
    Cortese M; Riise T; Engeland A; Ascherio A; Bjørnevik K
    Parkinsonism Relat Disord; 2018 Jul; 52():76-82. PubMed ID: 29615298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gout, hyperuricemia, and Parkinson's disease: a protective effect?
    Alonso A; Sovell KA
    Curr Rheumatol Rep; 2010 Apr; 12(2):149-55. PubMed ID: 20425025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gout is not associated with a lower risk of Parkinson's disease: A systematic review and meta-analysis.
    Ungprasert P; Srivali N; Thongprayoon C
    Parkinsonism Relat Disord; 2015 Oct; 21(10):1238-42. PubMed ID: 26330027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gout and the risk of Parkinson's disease in older adults: a study of U.S. Medicare data.
    Singh JA; Cleveland JD
    BMC Neurol; 2019 Jan; 19(1):4. PubMed ID: 30611222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal follow-up study of the association with gout and Alzheimer's disease and Parkinson's disease in Korea.
    Lee EJ; Kim SY; Choi HG; Kim YH; Kwon MJ; Kim JH; Lee HS; Oh JK; Chang IB; Song JH; Kim JH
    Sci Rep; 2023 Mar; 13(1):3696. PubMed ID: 36878976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arsenic exposure, hyperuricemia, and gout in US adults.
    Kuo CC; Weaver V; Fadrowski JJ; Lin YS; Guallar E; Navas-Acien A
    Environ Int; 2015 Mar; 76():32-40. PubMed ID: 25499256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NSAID use and risk of Parkinson disease: a population-based case-control study.
    Becker C; Jick SS; Meier CR
    Eur J Neurol; 2011 Nov; 18(11):1336-42. PubMed ID: 21457177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vegetarian diet and risk of gout in two separate prospective cohort studies.
    Chiu THT; Liu CH; Chang CC; Lin MN; Lin CL
    Clin Nutr; 2020 Mar; 39(3):837-844. PubMed ID: 30955983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of obesity and hypertriglyceridemia on gout development with or without hyperuricemia: a prospective study.
    Chen JH; Pan WH; Hsu CC; Yeh WT; Chuang SY; Chen PY; Chen HC; Chang CT; Huang WL
    Arthritis Care Res (Hoboken); 2013 Jan; 65(1):133-40. PubMed ID: 22933424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Septic arthritis in gout patients: a population-based cohort study.
    Lim SY; Lu N; Choi HK
    Rheumatology (Oxford); 2015 Nov; 54(11):2095-9. PubMed ID: 26170377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Re: Gout and risk of Parkinson disease: a prospective study.
    Iwasaki Y; Kano O; Ikeda K
    Neurology; 2008 Jul; 71(1):70; author reply 70. PubMed ID: 18591512
    [No Abstract]   [Full Text] [Related]  

  • 20. Association between previous history of gout attack and risk of deep vein thrombosis - a nationwide population-based cohort study.
    Chiu CC; Chen YT; Hsu CY; Chang CC; Huang CC; Leu HB; Li SY; Kuo SC; Huang PH; Chen JW; Lin SJ
    Sci Rep; 2016 May; 6():26541. PubMed ID: 27231197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.